BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Catheter Precision Makes NYSE American Section 610(b) Public Announcement

  April 18, 2025

   · 

  1 min read
• Press Releases

  Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 17, 2025

  April 18, 2025

   · 

  3 min read
• Press Releases

  Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

  April 18, 2025

   · 

  6 min read
• Press Releases

  Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

  April 18, 2025

   · 

  5 min read
• Press Releases

  Actum Pharma Expands Executive Team to Launch Enhanced Services Program to Support Biopharma Product Commercialization and Market Success

  April 18, 2025

   · 

  3 min read
• Press Releases

  Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit for these patients

  April 18, 2025

   · 

  7 min read
• Press Releases

  Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 17, 2025

  April 18, 2025

   · 

  2 min read
• Press Releases

  Children’s Hospital of Philadelphia Researchers Find Gene Therapy Shows Long-Term Benefits for Hemophilia B Patients

  April 18, 2025

   · 

  4 min read
• Press Releases

  BVI Medical Announces Approval of Breakthrough Technology: FDA 510(k) Clearance of its Laser Endoscopy Ophthalmic System: Leos™

  April 18, 2025

   · 

  3 min read
• Press Releases

  Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health’s Crofelemer to be Presented at April 2025 ELITE PED-GI Congress

  April 18, 2025

   · 

  7 min read